Skip to main content
SpringerLink
Log in

Zytostatika-Behandlung der Psoriasis

  • Conference paper
Fortschritte der praktischen Dermatologie und Venerologie

Part of the book series: Fortschritte der praktischen Dermatologie und Venerologie ((DERMATOLOGIE,volume 10))

Zusammenfassung

Die zytostatische Behandlung der Psoriasis ist mehr als 30 Jahre alt. 1951 untersuchte Gubner [10] zum ersten Mal den Wert von Aminopterin bei dieser Krankheit. 13 Patienten — 7 litten gleichzeitig an Arthritis psoriatica — wurden mit überzeugendem Effekt behandelt. Seitdem ist zuerst dieses Medikament und später sein Analogon, Methothrexat, auf der ganzen Welt bei schwerer, zu Invalidität führender Psorisis angewandt worden.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Atherton D, Wells R, Laurent M, Williams Y (1980) Razoxane in the treatment of psoriasis. Br J Dermatol 102:307–317

    Article  PubMed  CAS  Google Scholar 

  2. Bailin P, Tindall J, Roenigk H, Hogan M (1975) Is methotrexate therapy for psoriasis carcinogenic? A modified retrospective-prospective analysis. JAMA 232:359–362

    Article  PubMed  CAS  Google Scholar 

  3. Baker H, Wilkinson D (1979) Psoriasis. In: Rook A, Wilkinson D, Ebling F (eds) Textbook of dermatology. Blackwell, Oxford, pp 1315–1367

    Google Scholar 

  4. Baker H (1982) Antimitotic drugs in psoriasis. In: Farber E, Cox A (eds) Psoriasis, Proc III Int Symp. Grune & Stratton, New York, pp 119–126

    Google Scholar 

  5. Benedict W, Baker M, Haroun L, Choi E, Ames B (1977) Mutagenicity of cancer chemotherapeutic agents in the Salmonella/Microsome test. Cancer Res 37:2209–2213

    PubMed  CAS  Google Scholar 

  6. Black R, O’Brien W, van Scott E, Auerbach R, Eisen A, Bunim J (1964) Methotrexate therapy in psoriatic arthritis. JAMA 189:743–747

    Article  PubMed  CAS  Google Scholar 

  7. Dahl M, Comaish J (1972) Long-term effects of hydroxyurea in psoriasis. Br Med J IV:585–587

    Article  Google Scholar 

  8. Epstein W, Maibach H (1965) Immunologic competence of patients with psoriasis receiving cytotoxic drug therapy. Arch Dermatol 91:599–606

    Article  PubMed  CAS  Google Scholar 

  9. Grunnet E, Nyfors A, Brogaard Hansen K (1977) Studies on human semen in topical corticoid and in methotrexate treated psoriasis. Dermatologica 154:78–84

    Article  PubMed  CAS  Google Scholar 

  10. Gubner R (1951) Effect of aminopterin on epithelial tissues. Arch Dermatol Syph 64:688–699

    Article  CAS  Google Scholar 

  11. Jones E Linn, Frost P, Epinette W, Gomez E (1977) Mycophenolic acid-an evaluation of efficacy. In: Farber E, Cox A, Jacobs P, Nall M Lexie (eds) Psoriasis, Proc II Int Symp. Yorke Medical Books, New York, pp 440–441

    Google Scholar 

  12. Kragballe K, Zachariae E, Zachariae H (1982) Methotrexate in psoriatic arthritis—a retrospective study. Acta Derm Venereol (Stockh) 63:165–167

    Google Scholar 

  13. Milstein H, Cornell R, Stoughton R (1973) Azaribine in the treatment of psoriasis. Arch Dermatol 108:43–47

    Article  PubMed  CAS  Google Scholar 

  14. Morison W, Montaz K, Parrish J, Fitzpatrick T (1982) Combined methotrexate-PUVA therapy in the treatment of psoriasis. J Am Acad Dermatol 6:683–687

    Article  Google Scholar 

  15. Nielsen J, Zachariae H (1973) Chromosome aberrations in severe psoriasis. Acta Derm Venereol (Stockh) 53:192–194

    CAS  Google Scholar 

  16. Novotny F (1973) Innere Behandlung schwerer Psoriatiker mit Buthiopurin. Dermatol Monatsschr 159:986–990

    PubMed  CAS  Google Scholar 

  17. Nyfors A (1980) Methotrexate therapy of psoriasis. Dan Med Bull 27:7469–7500

    Google Scholar 

  18. Reed K, Sober A (1983) Methotrexate-induced necrolysis. J Am Acad Dermatol 8:677–679

    Article  PubMed  CAS  Google Scholar 

  19. Rees R (1968) Psoriasis and methotrexate. In: Waisman M (ed) Pharmacological therapeutics in dermatology. Thomas, Springfield, 111.

    Google Scholar 

  20. Roenigk H, Auerbach R, Maibach H, Weinstein G (1982) Methotrexate guidelines—revised. J Am Acad Dermatol 6:145–155

    Article  PubMed  Google Scholar 

  21. Shen D, Azarnoff D (1978) Clinical pharmacokinetics of methotrexate. Clin Pharmacokinet 3:1–13

    Article  PubMed  CAS  Google Scholar 

  22. Taylor J, Woodyard C, Halprin K (1982) In vivo effects of methotrexate on psoriatics epidermis. In: Färber E, Cox A (eds) Psoriasis, Proc III Int Symp. Grune & Stratton, New York, pp 389–390

    Google Scholar 

  23. Wahba A, Cohen H (1980) Therapeutic trials with oral colchicine in psoriasis. Acta Derm 60:515–520

    CAS  Google Scholar 

  24. Walsdorfer U, Christophers E, Schröder J-M (1983) Methotrexate inhibits polymorphonuclear leucocyte chemotaxis in psoriasis. Br J Dermatol 108:451–456

    Article  PubMed  CAS  Google Scholar 

  25. Weinstein G, Frost P (1971) Methotrexate for psoriasis—a new therapeutic schedule. Arch Dermatol 103:33–38

    Article  PubMed  CAS  Google Scholar 

  26. Weinstein G, Roenigk H, Maibach H, Cosmides J, Almeyda J, Auerbach R, Tobias H, Bergfeld W, Clyde D, Dahl M, Frost P, Schiff E, Krueger R, Tindall J, Lee J, Lundquist A, Schaffner F, Scheuer P, Zachariae H (1973) Psoriasis—liver—methotrexate interactions. Arch Dermatol 108:36–42

    Article  Google Scholar 

  27. Zachariae H, Kragballe K, Søgaard H (1980) Methotrexate induced liver cirrhosis. Br J Dermatol 102:407–412

    Article  PubMed  CAS  Google Scholar 

  28. Zachariae H, Bjerring P (1982) Methotrexate in psoriasis with and without leucovorin: Effect of different dosage schedules on acute liver toxicity. Acta Derm Venereol (Stockh) 62:446–448

    CAS  Google Scholar 

  29. Zachariae H (1983) Methotrexate and etretinate as concurrent therapies in the treatment of psoriasis. Arch Dermatol (in press)

    Google Scholar 

Download references

Authors
  1. Hugh Zachariae
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Universität München, Frauenlobstraße 9-11, D-8000, München 2, Deutschland

    Otto Braun-Falco (o. ö. Professor für Dermatologie und Venerologie Direktor der Dermatologischen Klinik und Poliklinik) & Günter Burg (Professor für Dermatologie und Venerologie Leitender Oberarzt der Dermatologischen Klinik und Poliklinik) (o. ö. Professor für Dermatologie und Venerologie Direktor der Dermatologischen Klinik und Poliklinik) &  (Professor für Dermatologie und Venerologie Leitender Oberarzt der Dermatologischen Klinik und Poliklinik)

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Zachariae, H. (1983). Zytostatika-Behandlung der Psoriasis. In: Braun-Falco, O., Burg, G. (eds) Fortschritte der praktischen Dermatologie und Venerologie. Fortschritte der praktischen Dermatologie und Venerologie, vol 10. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-82207-0_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-82207-0_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-13075-8

  • Online ISBN: 978-3-642-82207-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation